Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in SYK — Stryker Corp

CIK 886982 NEW YORK, NY
Back to SYK Full portfolio

Position in SYK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$876,445,924
-$835,155 QoQ
Shares Held
2,783,782
+4.3% QoQ
Ownership
0.726%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#22
of 2,216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in SYK Over Time

Shares Held

Position Value (USD)

Derivatives in SYK

reported options exposure · as of Jun 30, 2026
CallValue
$5,383,764
CallShares
17,100
PutValue
$6,170,864
PutShares
19,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $6,794,178,953 across 97 Medical Devices names. SYK ranks #2 (12.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 16,760,070 $1,520,808,749
2 SYK
Stryker Corp
This page 		2,783,782 $876,445,924
3 BSX
Boston Scientific Corp
 16,954,342 $723,611,313
4 MDT
Medtronic plc
 9,012,210 $705,025,184
5 EW
Edwards Lifesciences Corp
 4,549,113 $411,512,760
6 STE
STERIS plc
 1,363,145 $287,037,441
7 GEHC
GE HealthCare Technologies Inc.
 4,446,565 $284,624,625
8 PEN
Penumbra Inc
 847,104 $267,473,087

All Filings in SYK

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,170,864 19,600
2026-06-30 $876,445,924 2,783,782
2026-06-30 $5,383,764 17,100
2026-03-31 $877,281,079 2,669,835
2026-03-31 $4,567,401 13,900
2026-03-31 $7,557,570 23,000
2025-12-31 $755,620,430 2,149,886
2025-12-31 $5,096,315 14,500
2025-12-31 $5,096,315 14,500
2025-09-30 $3,881,535 10,500
2025-09-30 $1,109,010 3,000
2025-09-30 $903,938,521 2,445,258
2025-06-30 $800,943,436 2,024,476
2025-06-30 $989,075 2,500
2025-06-30 $1,186,890 3,000
2025-03-31 $825,425,288 2,217,395
2025-03-31 $930,625 2,500
2025-03-31 $12,284,250 33,000
2024-12-31 $3,816,530 10,600
2024-12-31 $29,200,055 81,100
2024-12-31 $742,544,435 2,062,337
2024-09-30 $29,298,186 81,100
2024-09-30 $3,829,356 10,600
2024-09-30 $734,903,268 2,034,278
2024-06-30 $2,756,025 8,100
2024-06-30 $689,256,332 2,025,735
2024-06-30 $12,963,525 38,100
2024-03-31 $1,073,610 3,000
2024-03-31 $1,073,610 3,000
2024-03-31 $736,025,501 2,056,684
2023-12-31 $14,973,000 50,000
2023-12-31 $725,917,091 2,424,087
2023-12-31 $10,001,964 33,400
2023-09-30 $9,127,218 33,400
2023-09-30 $13,663,500 50,000
2023-09-30 $628,633,311 2,300,411
2023-06-30 $605,086,215 1,983,304
2023-06-30 $15,254,500 50,000
2023-06-30 $7,627,250 25,000
2023-03-31 $7,136,750 25,000
2023-03-31 $557,970,239 1,954,567
2023-03-31 $29,117,940 102,000
2022-12-31 $379,221,592 1,551,072
2022-09-30 $289,400,290 1,428,855
2022-06-30 $218,539,125 1,098,573
2022-03-31 $384,337,011 1,437,580
2021-12-31 $327,321,543 1,223,998
2021-09-30 $377,115,642 1,429,985
2021-06-30 $320,021,123 1,232,130
2021-03-31 $282,656,075 1,160,424

Report a Problem

Category
Description
Email (optional, for follow-up)